LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Wen Zhang

Wen Zhang

LiveDNA ID: 86.41757
9 Publications
0 Editorial Roles
0 Projects

About

Professional Summary

Dr. Wen Zhang is currently a full professor with more than 30 years of research and teaching experience and Director of the Institute of New Drug R & D and Chemical Biology at Zhejiang University of Technology. In 2001, he entered Professor Ohrui’s Lab of Tohoku University, Japan, working in the field of molecular design, synthesis and recognition for two years as a JSPS postdoctoral fellow. In 2003, he joined Professor Sugiyama’s Chemical Biology group of Kyoto University, Japan, as COE and JST research fellows working on biology and chemistry of polyamide-nucleic acids interaction for more than two years. In 2006, he moved to Mie R & D Center of Chemical Soft R & D Inc., Japan as a principal scientist working on organic molecule synthesis and bioactive screening, and nanomedicine. In 2010, he joined the College of Pharmacy at Zhejiang University of Technology, Hangzhou, China. In recent years, Dr. ZHANG has received a number of honors and awards, including Leading Talent of Huzhou South Taihu Lake Elite Plan in 2013, the Third-class Prize of Zhejiang Medicine and Health Award in 2013, the First-class Prize of Zhejiang Medicine and Health Award in 2015, the First-class Prize of Scientific and Technological Progress Award of Zhejiang Province in 2015, the Second-class Prize of Outstanding Scientific Research Achievements of Higher Education Institutions by Ministry of Education in 2015, the Third-class Prize of Science and Technology Award of CPCIF in 2015, Zhejiang Thousand Talents Program expert in 2015, and winner of Huzhou New Century 1112 Talent Project in 2016. To date, Dr. Zhang has published better papers as the first/corresponding author in excellent Journals including J Am Chem Soc,J Med Chem, Euro J Med Chem, Cancer Lett, etc.

Education

Academic Background
  • Ph.D. East China University of Science and Technology, China Pharmacy | Completed: 2001

Publications (9)

Selected Scholarly Contributions
Small‐Molecule Inhibitors Targeting PD‐1/PD‐L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical Prospects
Jianwei Wang, Shenwei Yu, Liang Qian, Yanling Wu, Wen Zhang, Annoor Awadasseid
ChemMedChem | Journal Article
Crossref
2026
Research Progress and Clinical Translation Challenges of Small‐Molecule Inhibitors Targeting PD‐L1
Liang Qian, Ruyue Ni, Ping Lv, Yuxing Chai, Annoor Awadasseid, Xuqiong Xiong, Wen Zhang
ChemMedChem | Journal Article
Crossref
2026
Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity
Jianwei Wang, Shenwei Yu, Liang Qian, Jacek Plewka, Ruyue Ni, Chenyang Wang, Feng Zhang, Zeyu Chen, Annoor Awadasseid, Yanling Wu, Katarzyna Magiera-Mularz, Wen Zhang
Journal of Medicinal Chemistry | Journal Article
Crossref
2026
Impact of Tacrolimus Versus Cyclosporine on Overall Response, Complete Remission and Relapse in Nephrotic Syndrome: A Systematic Review and Meta-Analysis
Zhenjie Jin, Jia Sun, Wen Zhang
International Journal of Pharmacology | Journal Article
Crossref
2025
Progress in the Research and Development of Biphenyl Small Molecules Targeting PD‐1/PD‐L1 as Potential Antitumor Drug Candidates
Wei He, Haoran Xu, Annoor Awadasseid, Yanhua Song, Jianwei Wang, Wen Zhang
ChemMedChem | Journal Article
Crossref
2025
Antineuroblastoma Activity Evaluation and Mechanism of Novel PD-L1 Small Molecule Inhibitors through Immune and Non-Immune Pathways
Jianwei Wang, Yongnan Zhou, Zejie Chen, Xiaoyin Zhao, Haoran Xu, Feng Zhang, Awadasseid Annoor, Rui Wang, Caiyun Wu, Hua Zhang, Mengyu Zhu, Wen Zhang
ACS Pharmacology & Translational Science | Journal Article
Crossref
2025
Design, Synthesis and Biological Evaluation of Biphenyl-1,2,3-Triazole Hybrid Analogues as PD-1/PD-L1 Inhibitors
Shijia Zhou, Suresh Narva, Mengda Wu, Ming Wang, Feng Zhang, Chenfeng Shen, Annoor Awadasseid, Wen Zhang
International Journal of Pharmacology | Journal Article
Crossref
2024
Design, Synthesis, and Antitumor Activity Evaluation of 2-Arylmethoxy-4-(2,2′-dihalogen-substituted biphenyl-3-ylmethoxy) Benzylamine Derivatives as Potent PD-1/PD-L1 Inhibitors
Hua Zhang, Shijia Zhou, Jacek Plewka, Caiyun Wu, Mengyu Zhu, Qimeng Yu, Bogdan Musielak, Xiao Wang, Annoor Awadasseid, Katarzyna Magiera-Mularz, Yanling Wu, Wen Zhang
Journal of Medicinal Chemistry | Journal Article
Crossref
2023
Discovery of Pyrrole-imidazole Polyamides as PD-L1 Expression Inhibitors and Their Anticancer Activity via Immune and Nonimmune Pathways
Ming Wang, Xudong Ma, Kang Zhou, Huijuan Mao, Jiachun Liu, Xuqiong Xiong, Xiaoyin Zhao, Suresh Narva, Yoshimasa Tanaka, Yanling Wu, Chuanxin Guo, Hiroshi Sugiyama, Wen Zhang
Journal of Medicinal Chemistry | Journal Article
Crossref
2021